Clinical Outcomes of Bivalirudin Versus Heparin in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
单位：[1]Beijing Friendship Hospital, Capital Medical University, Beijing, China首都医科大学附属北京友谊医院[2]First Affiliated Hospital of Dalian Medical University, Dalian, China大连医科大学附属第一医院
第一作者单位：[1]Beijing Friendship Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714)：
Rongchong Huang,Shaoke Meng,Lei Guo.Clinical Outcomes of Bivalirudin Versus Heparin in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials[J].JOURNAL of the AMERICAN COLLEGE of CARDIOLOGY.2019,74(13):B636-B636.doi:10.1016/j.jacc.2019.08.768.
APA：
Rongchong Huang,Shaoke Meng&Lei Guo.(2019).Clinical Outcomes of Bivalirudin Versus Heparin in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.JOURNAL of the AMERICAN COLLEGE of CARDIOLOGY,74,(13)
MLA：
Rongchong Huang,et al."Clinical Outcomes of Bivalirudin Versus Heparin in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".JOURNAL of the AMERICAN COLLEGE of CARDIOLOGY 74..13(2019):B636-B636
医学